Beta-O2 Technologies Ltd.

beta-o2 is developing the ßair bio-artificial pancreas, intended to cure type 1 diabetes (tid). patients with tid are unable to produce insulin, a hormone needed to transport sugar into cells, providing the energy needed for daily life. ßair provides a viable and safe environment for islets of langerhans (insulin producing beta cells), to thrive and provide the body with insulin on demand. it is able to do so, as beta-o2 has solved the major challenges of islet transplantation – creating a protective environment where the cells can thrive but where the patient doesn’t need to take life-long immunosuppression drugs with unpleasant side effects, and of crucial importance, keeping the cells alive and functioning inside the recipient’s body.